Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The third volume of this series features 6 reviews:
-Advances in the understanding and treatment of immune thrombocytopenia
-Recent developments in chronic myeloid leukemia biology and treatment
-Role of immunomodulatory drugs in the treatment of lymphoid and myeloid malignancies
-Pediatric hematological malignancies – clinical manifestation, treatment and follow-up
-Novel therapies and immunotherapeutic approaches to treat childhood leukemia
-Erythrocyte turnover and erythropoietic patterns in two different experimental mouse models of anemia